Aduro Biotech Company Profile (NASDAQ:ADRO)

Analyst Ratings

Consensus Ratings for Aduro Biotech (NASDAQ:ADRO) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $24.17 (72.62% upside)

Analysts' Ratings History for Aduro Biotech (NASDAQ:ADRO)
Show:
DateFirmActionRatingPrice TargetActions
7/11/2016Roth CapitalReiterated RatingBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016FBR & CoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/17/2016Leerink SwannReiterated RatingOutperform$48.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Bank of America Corp.DowngradeBuy -> Underperform$32.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016William BlairInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2015Oppenheimer Holdings Inc.DowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Aduro Biotech (NASDAQ:ADRO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/2/2016Q116($0.25)($0.45)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q415($0.15)$0.04$34.38 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/24/2015Q3($0.08)$0.01$15.80 million$19.15 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.01)($0.50)$1.00 million$9.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/28/2015Q115($0.03)($39.97)$9.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Aduro Biotech (NASDAQ:ADRO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20168($0.52)($0.10)($0.29)
Q2 20167($0.46)$0.11($0.18)
Q3 20167($0.51)($0.20)($0.43)
Q4 20167($0.56)($0.21)($0.44)
Q1 20171($0.50)($0.50)($0.50)
Q2 20171($0.51)($0.51)($0.51)
Q3 20171($0.51)($0.51)($0.51)
Q4 20171($0.51)($0.51)($0.51)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Aduro Biotech (NASDAQ:ADRO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Aduro Biotech (NASDAQ:ADRO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/5/2016Thomas W DubenskyInsiderSell25,000$11.61$290,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Thomas W. DubenskyInsiderSell905$8.20$7,421.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2016Dirk G. BrockstedtVPSell22,000$21.77$478,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2016Gregory W. SchaferCOOSell20,000$23.58$471,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2016Jennifer LewVPSell5,242$25.71$134,771.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2016Stephen T. IsaacsCEOSell25,000$26.31$657,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Thomas W. DubenskyinsiderSell15,000$26.37$395,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Gregory W. SchaferCOOSell25,000$29.74$743,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Jennifer LewVPSell5,242$29.85$156,473.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015Stephen T. IsaacsCEOSell25,000$29.11$727,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2015Thomas W. DubenskyinsiderSell30,000$29.27$878,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2015Jennifer LewVPSell6,712$28.52$191,426.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2015Gregory W. SchaferCOOSell26,470$28.15$745,130.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2015Thomas W. DubenskyinsiderSell31,470$28.27$889,656.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2015Stephen T. IsaacsCEOSell25,000$27.54$688,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015Jennifer LewVPBuy2,000$17.00$34,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015Venture (Vi) Inves MorningsideMajor ShareholderBuy441,176$17.00$7,499,992.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015William Mariner GreenmanDirectorBuy3,000$17.00$51,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Aduro Biotech (NASDAQ:ADRO)
DateHeadline
07/22/16 07:38 AMWeather-related disruption could further boost thermal coal prices: analysts - [at noodls] - Thermal coal prices could get a further boost this year from potentially continuing weather-related disruptions to Indonesian and Australian production and ongoing industry reforms in China, analysts at ...
07/22/16 07:38 AMChina’s June coal output falls 17% on year to 277.54 million mt - [at noodls] - Hunan, China (Platts)-15 Jul 2016 324 am EDT/724 GMT China mined 277.54 million mt of crude coal in June, down 16.6% on year, according to figures released by the National Bureau of Statistics on Friday. ...
07/22/16 07:38 AMDomestic coal consumption cushions low global demand - [at noodls] - Amid declining global demand for coal, Indonesia is still seeing a gradual rise in domestic consumption for the commodity, driven mainly by the operation of new steam-fueled power plants and higher demand ...
07/20/16 09:08 PMAduro BioTech Inc Has Another Very Strong Trading Session - Consumer Eagle
07/20/16 09:08 PMAduro BioTech Inc (NASDAQ:ADRO) Expected To Post Sales Of $139.845 - Investor Newswire
07/19/16 02:19 PMShares Losing Ground in Session: Aduro BioTech, Inc. (NASDAQ:ADRO) - TGP
07/18/16 02:18 PMToday's Watch List: Galapagos NV (NASDAQ:GLPG), Aduro BioTech, Inc. (NASDAQ:ADRO), Apogee Enterprises, Inc ... - KC Register
07/18/16 04:38 AMChina reaffirms plan to cut steel and coal production - [at noodls] - China will use all means to meet its goal to cut steel and coal capacity this year despite local reluctance to reduce output as prices rise, China's top economic planner said on Thursday. ... This is an ...
07/17/16 02:17 PMStrong Sell Calls For Aduro BioTech Inc (NASDAQ:ADRO) At 0 - Investor Newswire
07/16/16 02:18 PMCrowd Rating and Earnings Recap for Aduro BioTech Inc (NASDAQ:ADRO) - Telanagana Press
07/16/16 02:18 PMAduro Biotech Incorporated (NASDAQ:ADRO) Short Interest Increased By 14.17% - Press Telegraph
07/15/16 10:28 AMChina to cut coal mining capacity of SASAC-owned companies by 10% in 2 years - [at noodls] - Hunan, China (Platts)-11 Jul 2016 451 am EDT/851 GMT China's State-owned Assets Supervision and Administration Commission is set to eliminate coal and steel capacity of SASAC-owned companies by 10% over ...
07/14/16 02:19 PMAduro BioTech Inc (NASDAQ:ADRO) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/14/16 02:19 PMAduro BioTech Inc Realized Volatility Hits Extreme Level - CML News
07/13/16 07:51 PMIs Selling Aduro BioTech Inc Here a Winning Strategy? - Consumer Eagle
07/13/16 02:20 PMAduro Biotech Incorporated (NASDAQ:ADRO) Shorted Shares Increased 14.17% After Market Selling - Consumer Eagle
07/12/16 02:20 PMTrading Performance and Target Watch for Aduro BioTech Inc (NASDAQ:ADRO) - Press Telegraph
07/11/16 02:18 PMAduro BioTech Inc (NASDAQ:ADRO) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/11/16 07:43 AMEmerging Markets to Drive the Future of Coal - [at noodls] - World demand for coal is expected to grow by 7 percent through 2030 as a result of emerging markets prioritizing cost effective energy production methods over environmental sustainability. India and Southeast ...
07/11/16 07:43 AMCoal price forecast to rise on production fall - [at noodls] - JOHANNESBURG (miningweekly.com) - A greater-than-expected decline in global mine production, predominately in China, has prompted Fitch group company BMI Research to forecast higher coal prices. The research ...
07/11/16 07:43 AMCoal consumption forecast to gain 2.7% this year - [at noodls] - South Korea's coal consumption is expected to grow nearly 3 percent in 2016 from a year earlier, a report said Thursday, despite government efforts to cut back on coal-fired power generation to tackle ...
07/10/16 02:18 PMIs $22 Within Reach For Aduro BioTech Inc (NASDAQ:ADRO)? - Investor Newswire
07/10/16 07:06 AMAduro Biotech, Inc. (NASDAQ:ADRO) Broker Price Targets For The Coming Week - Fiscal Standard
07/09/16 10:25 AMAduro Biotech Incorporated (NASDAQ:ADRO) Shorted Shares Increased By 14.17% - Engelwood Daily
07/07/16 07:37 PMAduro Biotech, Inc. (NASDAQ:ADRO) Trading Up – Insiders Are Selling
07/07/16 02:19 PMAduro BioTech Inc (NASDAQ:ADRO) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/06/16 07:05 AMStock Rating Watch and Earnings Insight for Aduro BioTech Inc (NASDAQ:ADRO) - Press Telegraph
07/05/16 10:57 AMAduro BioTech, Inc. – Value Analysis (NASDAQ:ADRO) : July 5, 2016 -
07/04/16 02:18 PMShare Performance Recap for: Aduro BioTech, Inc. (NASDAQ:ADRO) - Press Telegraph
07/04/16 07:08 AMAduro BioTech, Inc. breached its 50 day moving average in a Bullish Manner : ADRO-US : July 4, 2016 -
07/04/16 07:05 AMAduro BioTech Inc (NASDAQ:ADRO) Expected to Reach Highs Of $22 - Investor Newswire
07/04/16 07:05 AMBroker Outlook For The Week Ahead Aduro Biotech, Inc. (NASDAQ:ADRO) - Fiscal Standard
07/01/16 02:18 PMTracking Stock Volatility for: Aduro BioTech, Inc. (NASDAQ:ADRO) - Engelwood Daily
07/01/16 02:18 PMAduro Biotech, Inc. (NASDAQ:ADRO) Updated Price Targets - FTSE News
07/01/16 02:18 PMShares Headed Up in Session: Aduro BioTech, Inc. (NASDAQ:ADRO) - Telanagana Press
06/30/16 02:19 PMAduro BioTech Inc (NASDAQ:ADRO) Company Rating and Target Watch - Telanagana Press
06/29/16 07:28 PMAduro BioTech Inc (NASDAQ:ADRO) Yearly Sales Target At $212.495 - Investor Newswire
06/29/16 10:27 AMShare Update and Earnings Review for Aduro BioTech Inc (NASDAQ:ADRO) - Press Telegraph
06/29/16 10:27 AMRecently Issued Stock Ratings For Aduro Biotech, Inc. (NASDAQ:ADRO) - Fiscal Standard
06/28/16 08:31 AM4 Biotechs with Blockbuster Potential for Multiple Cancer Indications -
06/27/16 02:40 PMAduro BioTech Inc (NASDAQ:ADRO) Earnings Glance and Target Price Review - Engelwood Daily
06/27/16 07:05 AMStrong Sell Calls Recommendations For Aduro BioTech Inc (NASDAQ:ADRO) At 0 - Investor Newswire
06/25/16 09:44 AMAduro Biotech Incorporated (NASDAQ:ADRO) Shorted Shares Increased 14.17% After Market Selling - Engelwood Daily
06/25/16 09:44 AMTwo Stocks within Analysts Limelight: Aduro Biotech, Inc. (NASDAQ:ADRO) , Trevena, Inc. (NASDAQ:TRVN) - Street Updates
06/23/16 10:03 AMAduro BioTech : Healthcare Sector Equities Under the Scanner - Alkermes, AMAG Pharma, IDEXX Laboratories, and Aduro BioTech
06/21/16 07:05 AMAduro Biotech, Inc. (NASDAQ:ADRO) Current Analyst Ratings - Fiscal Standard
06/21/16 03:29 AMBHP Billiton targets another $US600 million from coal arm by June 2017 - [at noodls] - Man pleads guilty to posting abusive comments about Nova Peris on Facebook Mining giant BHP Billiton says it is aiming to earn another $US600 million from its coal business by the end of the 2017 financial ...
06/20/16 02:18 PMStrong Buy Calls Count For Aduro BioTech Inc (NASDAQ:ADRO) At 4 - Investor Newswire
06/19/16 07:05 AMAduro Biotech, Inc. (NASDAQ:ADRO) Analyst Price Targets For The Coming Week - Fiscal Standard
06/16/16 06:28 AMAduro BioTech Inc (NASDAQ:ADRO) Yearly Sales Estimate At $212.495 - Investor Newswire

Social

About Aduro Biotech

Aduro Biotech logoAduro Biotech, Inc. is a clinical-stage immunotherapy company, which focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases. Its technologies are based on live, attenuated, double-deleted Listeria mononcytogenes (LADD) and cyclic dinucleotides (CDNs). It also develops LADD-based products, both as monotherapies and in combination with conventional cancer treatments. Its LADD technology platform is based on attenuated strains of Listeria that are engineered to express tumor-associated antigens to induce specific and targeted immune responses. Its CDN platform activates the intracellular stimulator of interferon genes (STING) receptor resulting in a tumor-specific immune response. Its B-select Antibody platform technology is based on in vitro clonal expansion of antibody producing cells (B cells) isolated from the spleen or lymph nodes of immunized mice, followed by immortalization of selected B cells through electro fusion.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADRO
  • CUSIP:
Key Metrics:
  • Previous Close: $13.67
  • 50 Day Moving Average: $12.03
  • 200 Day Moving Average: $13.89
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $904.55M
  • Beta: 3.55
  • Current Year EPS Consensus Estimate: $-1.45 EPS
  • Next Year EPS Consensus Estimate: $-1.36 EPS
Additional Links:
Aduro Biotech (NASDAQ:ADRO) Chart for Saturday, July, 23, 2016